Drug Trial Radar · NCT00941798
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Last checked: Nov 19, 2026Latest source record: Aug 31, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,283
Actual
Start
Jul 2009
Primary completion
May 2011
Study completion May 2011
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jul 20, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study CQMF149A2210 evaluated the safety of QMF149 Twisthaler® 500/400 μg, a fixed dose combination of indacaterol 500 μg, a once daily β2 agonist, and mometasone furoate 400 μg, an inhaled corticosteroid (ICS) that is approved for use in the treatment of asthma. The objective of this safety trial was to assess the effect of treatment on the incidence of serious asthma exacerbations, defined as asthma related hospitalization and/or intubation and/or death. This was an event driven trial.
Conditions
- Asthma
Interventions
QMF149 Twisthaler®Drug
Once daily via multi-dose dry-powder inhaler
Mometasone Twisthaler®Drug
Once daily via multi-dose dry-powder inhaler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Serious Asthma ExacerbationTime frame: Up to 21 months
Locations
146 sites in 9 countries. Site status is shown where the registry gives one.
Novartis Investigator Site
Birmingham, Alabama
Novartis Investigator Site
Buena Park, California
Novartis Investigator Site
Encinitas, California
Novartis Investigator Site
Fullerton, California
Novartis Investigator Site
Long Beach, California
Novartis Investigator Site
Los Angeles, California
Novartis Investigator Site
Orange, California
Novartis Investigator Site
Riverside, California
Novartis Investigator Site
San Diego, California
Novartis Investigator Site
San Jose, California
Novartis Investigator Site
San Mateo, California
Novartis Investigator Site
Vista, California
Novartis Investigator Site
Walnut Creek, California
Novartis Investigator Site
Denver, Colorado
Novartis Investigator Site
Engelwood, Colorado
Novartis Investigator Site
Lakewood, Colorado
Novartis Investigator Site
Wheat Ridge, Colorado
Novartis Investigator Site
Clearwater, Florida
Novartis Investigator Site
Clearwater, Florida
Novartis Investigative Site
Miami, Florida
Novartis Investigative Site
Miami, Florida
Novartis Investigator Site
Port Charlotte, Florida
Novartis Investigator Site
Sarasota, Florida
Novartis Investigative Site
South Miami, Florida
Novartis Investigator Site
Tampa, Florida
Novartis Investigative Site
Albany, Georgia
Novartis Investigative Site
Columbus, Georgia
Novartis Investigative Site
Savannah, Georgia
Novartis Investigator Site
Couer D'Alene, Idaho
Novartis Investigator Site
Chicago, Illinois
Novartis Investigator Site
Normal, Illinois
Novartis Investigator Site
River Forest, Illinois
Novartis Investigator Site
Skokie, Illinois
Novartis Investigator Site
Springfield, Illinois
Novartis Investigator Site
Evansville, Indiana
Novartis Investigator Site
Indianapolis, Indiana
Novartis Investigator Site
Iowa City, Iowa
Novartis Investigator Site
Topeka, Kansas
Novartis Investigator Site
Owensboro, Kentucky
Novartis Investigator Site
Metarie, Louisiana
Showing 40 of 146 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.